An interesting interview with Medace CEO Danielle Curfs and CBO Kurt Gielen by Brightlands has just been published, with InoCells as just one of the companies that is developing a scientifically based idea into a concrete therapy, with Medace’s help.
Medace Daniëlle Curfs can’t disclose the details yet, but startup InoCells will be announcing great news soon: stem cell therapy for women who have a hard time getting pregnant.
“Specifically developed for women suffering from ovarian insufficiency, which stops the maturation of eggs. We are in talks with Dr. Ron van Golde, head of the reproductive medicine division at Maastricht UMC+, to start the clinical testing phase here. If this study confirms what has been shown in the labs, it will be a global breakthrough. We’re really curious.”